Footprint Pharma ApS: Financial statements 2017
CVR: 37165174
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
Footprint Pharma ApS (CVR 37165174) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK -143,720 and a net result of DKK -143,720. Equity in the 2017 report amounted to DKK 760,495. The solvency ratio was 100%.
- Revenue
- DKK 0
- Gross Profit
- DKK -143,720
- Profit/Loss
- DKK -143,720
- Equity
- DKK 760,495
- Total Assets
- DKK 760,495
Official annual report
Keep an eye on Footprint Pharma ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
Footprint Pharma ApS has published its interim report for the period October 17, 2015 – December 31, 2016.
About Footprint Pharma ApS
Footprint Pharma ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2015. The company has been dissolved on 26 November 2021. The company was registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named vHL Group ApS. In 2020, the company reported a gross profit of DKK -1,263 and a net result of DKK 5,851 compared with DKK -59,461 the year before. Equity in the 2020 report amounted to DKK 466,267.